Setting 
My Cart
Toggle Nav
Close
  • Menu
  • Setting

L-NAME hydrochloride

Catalog No.
A7088
A nitric oxide synthase inhibitor, commonly used to construct hypertension (endothelial dysfunction) animal models.
Grouped product items
Size Price Stock Qty
100mg
$50.00
In stock
500mg
$72.00
In stock
1g
$116.00
In stock
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

L-NAME Hydrochloride (Nomega-nitro-L-arginine methyl ester hydrochloride; CAS 51298-62-5) is a nitric oxide synthase (NOS) inhibitor with an IC50 of 70 micromol/L[1]. NOS is the enzyme involved in NO production; NO is the smallest known signaling molecule, regulating autoregulatory functions such as neurotransmission and vascular tone, modulating gene transcription and mRNA translation, and producing post-translational modifications of proteins[2]. In the concentration range of 10(-9) to 10(-3) M, L-NAME hydrochloride inhibits NOS purified from rat brain in a dose-dependent manner, with an IC50 of 70 micromol/L[1]. In another study, 0.1-100 mM L-NAME hydrochloride produced concentration-dependent inhibition of Ca(2+)-dependent endothelial NOS from porcine aorta and caused endothelium-dependent contraction, inhibiting acetylcholine (ACh)-induced endothelium-dependent relaxation[3]. In anesthetized rats, L-NAME hydrochloride (0.03-300 mg/kg, intravenous) dose-dependently raises mean systemic arterial blood pressure accompanied by bradycardia; 100 mg/kg intravenously significantly inhibits the hypotensive responses to ACh and bradykinin; its pressor and bradycardic effects are dose-dependently reversed by L-arginine (30-100 mg/kg, intravenous)[3].

[1]. Pfeiffer S, Leopold E, Schmidt K, et al. Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-L-arginine. British Journal of Pharmacology, 1996, 118(6): 1433-1440.

[3]. Rees D D, Palmer R M, Schulz R, et al. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. British Journal of Pharmacology, 1990, 101(3): 746-752.

Long-term administration of L-NAME inhibits NO synthesis, causing endothelial dysfunction and elevated blood pressure, and is commonly used to establish hypertension (endothelial dysfunction) animal models.

[2]. Forstermann U, Sessa W C. Nitric oxide synthases: regulation and function. European Heart Journal, 2012, 33(7): 829-837.

Product Citation

Chemical Properties

Physical AppearanceA solid
StorageStore at -20°C
M.Wt269.7
Cas No.51298-62-5
FormulaC7H15N5O4·HCl
SynonymsL-NAME, L-NAME HCL
Solubility≥27 mg/mL in H2O; insoluble in EtOH; ≥23 mg/mL in DMSO
Chemical Namemethyl (2S)-2-amino-5-[[amino(nitramido)methylidene]amino]pentanoate;hydrochloride
Canonical SMILES[C@H](CCCNC(NN(=O)=O)=N)(C(OC)=O)N.Cl
Shipping ConditionSmall Molecules with Blue Ice, Modified Nucleotides with Dry Ice.
General tips We do not recommend long-term storage for the solution, please use it up soon.

Protocol

Cell experiment:[1]

Cell lines

Bovine retinal endothelial cells (BRECs) and rat retinal müller cell line rMC-1

Reaction Conditions

1 mM L-NAME for 5 d incubation

Applications

L-NAME inhibited production of NO and prostaglandin E2 as well as expression of iNOS and COX-2 in rMC-1 cells exposed to 25 mM glucose. Moreover, L-NAME also reduced BREC and rMC-1 cell death in the high glucose condition.

Animal experiment:[2]

Animal models

Male Wistar rats, 200 ~ 300 g

Dosage form

0.03 ~ 300 mg/kg

Intravenous administration (i.v.)

Applications

L-NAME (0.03 ~ 300 mg/kg, i.v.) induced a dose-dependent increase in mean systemic arterial blood pressure accompanied by bradycardia. Furthermore, L-NAME (100 mg/kg, i.v.) inhibited significantly the hypotensive responses to acetylcholine and bradykinin. The increases in blood pressure and bradycardia produced by L-NAME were reversed by L-arginine (30 ~ 100 mg/kg, i.v.) in a dose-dependent manner. Therefore, L-NAME could be used to study the important role of NO synthesis in the maintenance of vascular tone and blood pressure.

Note

The technical data provided above is for reference only.

References:

1. Du Y, Sarthy VP, Kern TS. Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2004, 287(4): R735-741.

2. Rees DD, Palmer RM, Schulz R, et al. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. British Journal of Pharmacology, 1990, 101(3): 746-752.

Biological Activity

Description L-NAME hydrochloride is a NO synthase inhibitor.
Targets            
IC50            

Quality Control

User Guide